Send feedback

TTN p.Pro22355Ser

c.67063C>T · rs794729481 · VCV202804

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.9763 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 8.48e-05%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, REVEL · SaProt no call
Conditions
5
myopathy, myofibrillar, 9, with early respiratory failure

Computational evidence

Protein change
AlphaMissense0.9763likely pathogenic · top 7% in TTN
REVEL0.768pathogenic-leaning
SaProt—not scored · why
⇒ AlphaMissense and REVEL both call this damaging; SaProt makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.9, phastCons 1
Regional constrainto/e 0.93unconstrained · MANE · 75 kb · p 3.1e-23 · regional, not allelic
Overall
CADD21.8PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P20714S vs ClinVar P22355S) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.48e-05% European (non-Finnish) · 1/1,179,286 alleles
Overall 0.000744% 12/1,612,046 alleles · very rare exomes 10/1,460,006 · genomes 2/152,040 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0271% 3,696
Remaining individualsnot grpmax-eligible 0.00481% 20,787
European (non-Finnish)grpmax 8.48e-05% 1,179,286

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TTN
Protein
p.Pro22355Ser
Coding
c.67063C>T
MANE Select
NM_001267550
dbSNP
rs794729481
Type
single nucleotide variant
Location
chr2:178580224 (GRCh38)
Gene constraint
LOEUF 0.479 · pLI <0.01 · ClinGen HI 2/3 (gnomAD)
Full TTN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ttn-p-pro22355ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown